Chemical Biology of Carbohydrates , Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research , D-66123 Saarbrücken , Germany.
Deutsches Zentrum für Infektionsforschung (DZIF) , Standort Hannover, D-38124 Braunschweig , Germany.
J Med Chem. 2019 Oct 24;62(20):9201-9216. doi: 10.1021/acs.jmedchem.9b01120. Epub 2019 Oct 11.
Biofilm formation is a key mechanism of antimicrobial resistance. We have recently reported two classes of orally bioavailable -glycosidic inhibitors of the lectin LecB with antibiofilm activity. They proved efficient in target binding, were metabolically stable, nontoxic, selective, and potent in inhibiting formation of bacterial biofilm. Here, we designed and synthesized six new carboxamides and 24 new sulfonamides for a detailed structure-activity relationship for two clinically representative LecB variants. Sulfonamides generally showed higher inhibition compared to carboxamides, which was rationalized based on crystal structure analyses. Substitutions at the thiophenesulfonamide increased binding through extensive contacts with a lipophilic protein patch. These metabolically stable compounds showed a further increase in potency toward the target and in biofilm inhibition assays. In general, we established the structure-activity relationship for these promising antibiofilm agents and showed that modification of the sulfonamide residue bears future optimization potential.
生物膜形成是抗菌药物耐药性的关键机制。我们最近报道了两类具有抗生物膜活性的、可口服的β-糖苷类 LecB 凝集素抑制剂。它们在靶标结合方面表现出高效,代谢稳定,无毒性,选择性,在抑制细菌生物膜形成方面具有很强的抑制作用。在这里,我们设计并合成了六个新的羧酰胺和 24 个新的磺酰胺,以对两种具有临床代表性的 LecB 变体进行详细的结构活性关系研究。磺酰胺类化合物通常比羧酰胺类化合物具有更高的抑制活性,这可以根据晶体结构分析进行合理化解释。噻吩磺酰胺的取代通过与亲脂性蛋白斑的广泛接触增加了结合。这些代谢稳定的化合物对靶标和生物膜抑制试验的活性进一步提高。总的来说,我们建立了这些有前途的抗生物膜剂的结构活性关系,并表明磺酰胺残基的修饰具有未来的优化潜力。